Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0000805928-21-000184

Chief R&D Officer gave up 286 shares (to pay taxes)

  • Chief R&D Officer acquired 1,150 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Scopelianos Angelo Chief R&D Officer 2021-12-27 Option exercise +1,150 11,270 D: show line 1 in the form
Scopelianos Angelo Chief R&D Officer 2021-12-27 Shares withheld for taxes −286 $9.74 $2,786 10,984 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Scopelianos Angelo Chief R&D Officer 2021-12-27 Option exercise · Restricted Stock Units −1,150 1,150 D: show line 3 in the form
Loading xslF345X03/wf-form4_164081344903243.xml…